-
-
-
-
-
-
-
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Viridian Therapeutics, Inc. (VRDN) Tops Q3 EPS by 16c
-
-
-
-
-
-
-
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh
-
-
-
-
-
-
-
Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
-
-
-
-
-
-
-
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
-
-
1,199,550 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

